Sinopharm, a state-controlled company, said its candidate was shown to be 79 percent effective in interim late-stage trials, bringing a China-made vaccine a step closer to approval for mass use.
Musical medicine? Corona-fighting herbs? “Human beings haven’t changed all that much,” a marketing professor says of the similarities between ads from 1918 and recent months.
A C.D.C. division is working with an industry standards group to develop filtration standards — and products that meet them will be able to carry labels saying so.
The blessing of these experts means that the agency will OK the vaccine’s use, paving the way for health care workers to begin getting shots next week.
Health experts say the E.P.A. decision defies scientific research showing that particulate pollution contributes to tens of thousands of premature deaths annually.
The Georgia Republican’s stock trades have far outpaced those of his Senate colleagues and have included a range of companies within his Senate committees’ oversight, an analysis shows.
Emergency approval of the vaccine, ahead of the United States and the European Union, clears the way for Britain to begin mass inoculations.
From trade and sanctions to tax policy and financial regulation, the former Fed chair will be at the center of the new administration’s agenda.